Research Article

Packaging challenge for COVID-19 drug

Anupam Chand*

Published: 11/09/2020 | Volume 4 - Issue 1 | Pages: 028-036

At present Corona virus is the most burning topic across the world. At present there is no drug available to cure 100%. So many companies are trying to make it possible as soon as they can.

Read Full Article HTML DOI: 10.29328/journal.abb.1001019 Cite this Article

References

  1. www.pda.org
  2. www.glass-ts.com
  3. www.sciencedirect.com
  4. Highlights from June 2011 Glass Container Delamination Scientific Symposium. 2013. http://www.rx-360.org/LinkClick.aspx?
  5. Swift, Rob Amgen presentations, PDA April 2011 San Antonio; PDA/FDA Glass Quality Conference May 2011.
  6. http://www.fda.gov/Drugs/DrugSafety/ucm248490.htm
  7. Ennis RD, Pritchard R, Nakamura C, Coulon M, Yang T, et al. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination. Pharm Dev Tech. 2001; 6: 393-405. PubMed: https://pubmed.ncbi.nlm.nih.gov/11485181/
  8. Desmond H. USP Presentation, PDA/FDA Glass Quality Conference May 2013.
  9. https://www.sciencedaily.com/releases/2020/09/200915152448.htm
  10. https://youtu.be/FD0fhZB3bUE
  11. https://investor.regeneron.com/static-files/a596a85e-e72d-4529-8eb5-d52d87a99070
  12. https://www.businessinsider.com/regeneron-ceo-says-trump-antibody-drug-experience-weakest-evidence-success-2020-10
  13. https://www.cbsnews.com/news/transcript-regeneron-ceo-leonard-schleifer-on-face-the-nation-october-11-2020/